AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 29071949
Drug: Electroacupuncture (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture (EA) stimulation of Zusanli (ST 36) and Neiguan (PC 6) for 30 min, once daily for 5 days
Trial: 25175124
Drug: Intravenous ultra-high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ultra-high dose methylcobalamin (MeCbl), 25 mg/day for 10 days followed by monthly 25 mg for 5 months
Trial: 25175124
Drug: Intravenous ultra-high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ultra-high dose methylcobalamin (MeCbl)
Trial: 21967833
Drug: Edaravone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edaravone (30 mg) during t-PA infusion
Trial: 21967833
Drug: Non-Edaravone (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-Edaravone (no edaravone during t-PA infusion)
Trial: 15222407
Drug: Simvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (40 mg)
Trial: 12052282
Drug: Lipid disorder
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid disorder therapy (specific treatment for lipid disorder)
Trial: 12052282
Drug: Lipid disorder
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid disorder therapy (for primary prevention of heart disease)
Trial: 9671997
Drug: Diode laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diode laser therapy
Trial: 7924321
Drug: Progestogen-only contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progestogen-only contraceptives (pill, DMPA, NET-EN, NORPLANT implants)
Trial: 2810536
Drug: Cefamandole (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefamandole (1 gm intravenously every 6 hours for nine doses)
Trial: 2810536
Drug: Cefazolin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin (1 gm intravenously every 6 hours for nine doses)
Trial: 28645473
Drug: Warfarin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin with non-DHP CCBs
Trial: 22995326
Drug: Fosfomycin trometamol
RxNorm normalized name: trometamol
DrugBank: Tromethamine (DB03754)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fosfomycin trometamol (FMT) 3g, 2 doses separated by 72 hours
Trial: 19793846
Drug: 500 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg/d anthocyanins as cyanidin glycosides (from elderberry) for 12 weeks
Trial: 8422624
Drug: Phase II
RxNorm normalized name: Coxiella burnetii phase II Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phase II single agents (MGBG, DHAD, AZQ)
Trial: 27416102
Drug: Risperidone ISM
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Risperidone ISM (all doses)
Trial: 20202147
Drug: Budesonide 800
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide 800 mcg/day
Trial: 20202147
Drug: Montelukast 5
RxNorm normalized name: montelukast 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 5 or 10 mg tablet according to age
Trial: 18284403
Drug: Methylprednisolone aceponate
RxNorm normalized name: Methylprednisolone aceponate
DrugBank: Methylprednisolone aceponate (DB14643)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone aceponate (MPA) 0.1% cream twice weekly plus emollient (Advabase)
Trial: 15665203
Drug: Therapeutic needle
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic needle treatment
Trial: 15665203
Drug: Placebo needle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo needle treatment
Trial: 12856118
Drug: Isovolaemic HVHF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isovolaemic HVHF (6 l/h of replacement fluid) with varying pre-dilution rates
Trial: 10096930
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment consisting of omeprazole, clarithromycin, and tinidazole in H pylori-positive patients and clarithromycin alone in C pneumoniae-positive patients.
Trial: 8902551
Drug: Ramipril at
RxNorm normalized name: Ramipril
DrugBank: Ramipril (DB00178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ramipril at previous doses (treated group T, n = 8)
Trial: 30219454
Drug: Placebo applied
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo applied twice a day for 3 weeks (placebo group)
Trial: 23227307
Drug: Standard-dose Tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-dose Tacrolimus (SD) with EC-MPS 720mg bid
Trial: 18396035
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg morphine/bolus (MO group)
Trial: 18396035
Drug: Subanaesthetic ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subanaesthetic ketamine plus 2/3 the standard dose of morphine
Trial: 12617614
Drug: Buckwheat honey
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buckwheat honey (1.5 g/kg body weight)
Trial: 11067718
Drug: Pneumo 23°
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumo 23° pneumococcal vaccine
Trial: 11067718
Drug: Older pneumococcal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Older pneumococcal vaccines
Trial: 1317764
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg of lithium carbonate
Trial: 1317764
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg of lithium carbonate
Trial: 15761201
Drug: High-flow oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flow oxygen therapy via facemask for 8 hours
Trial: 10849219
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion of 50 mU insulin/mL at 1 mL/h
Trial: 9380317
Drug: 21‐mg transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 21‐mg transdermal nicotine for 8 hours
Trial: 8230691
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg TNG solution (Solution group)
Trial: 8230691
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg TNG spray (Spray group)
Trial: 20220746
Drug: Acetaminophen-Placebo (AP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen-Placebo (AP)
Trial: 20220746
Drug: Acetaminophen-Ondansetron (AO)
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetaminophen-Ondansetron (AO)
Trial: 18586925
Drug: Chemotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy and radiation therapy (combined modality treatment)
Trial: 11219367
Drug: Supervised injectable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised injectable methadone maintenance treatment (MMT)
Trial: 25262567
Drug: Oral methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral methadone maintenance treatment (MMT)
Trial: 9379379
Drug: Topical timolol
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topical timolol 0.5% gel (Timoptic XE)
Trial: 9379379
Drug: Oral, sustained‐release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral, sustained‐release acetazolamide (Diamox Sequels)
Trial: 1327628
Drug: Captopril (6.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (6.25 mg followed by 25 mg 2 h later)
Trial: 2427842
Drug: Celiprolol 200
RxNorm normalized name: celiprolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol 200 or 400 mg
Trial: 2427842
Drug: Propranolol 40
RxNorm normalized name: propranolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40 or 80 mg
Trial: 27053325
Drug: Rifampin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin (600 mg/day for 10 days)
Trial: 21095333
Drug: ACEi plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACEi plus β‐blockers (ramipril plus metoprolol)
Trial: 18678789
Drug: Rasagiline 0.5
RxNorm normalized name: rasagiline 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline 0.5 mg daily
Trial: 18678789
Drug: Rasagiline 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline 1.0 mg daily
Trial: 9598252
Drug: 0.1 mg.kg-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg.kg-1 rocuronium
Trial: 9598252
Drug: 0.1 mg.kg-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg.kg-1 atracurium
Trial: 9598252
Drug: 0.1 ml.kg-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 ml.kg-1 normal saline (placebo)
Trial: 8181203
Drug: Computer-assisted heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-assisted heparin therapy
Trial: 3119776
Drug: RX77368 (thyrotrophin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RX77368 (thyrotrophin releasing hormone analogue), iv over 2 hours
Trial: 31933472
Drug: Domperidone 10
RxNorm normalized name: domperidone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone 10 mg oral dose after 10 hours of fasting
Trial: 31933472
Drug: Domperidone 10
RxNorm normalized name: domperidone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone 10 mg oral dose 30 minutes after a high-fat meal
Trial: 29327733
Drug: Oral appliance
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral appliance
Trial: 15879357
Drug: Estrogen discontinuation
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen discontinuation after 28 days
Trial: 12578771
Drug: Mitomycin-C (MMC)
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin-C (MMC) application during silicone intubation (SI) at 0.2 mg/ml for 2 minutes before SI
Trial: 10475361
Drug: RT plus
RxNorm normalized name: Recort Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT plus immediate androgen suppression (LHRH agonist)
Trial: 26149129
Drug: Pitavastatin 2
RxNorm normalized name: PITAVASTATIN 2MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitavastatin 2 mg/day
Trial: 27206047
Drug: DOVE treatment
RxNorm normalized name: Dove DermaSeries
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DOVE treatment group
Trial: 18241321
Drug: XR‐NTX 380
FDA approved: no
EMA approved: no
PMDA approved: no
Description: XR‐NTX 380 mg
Trial: 12385694
Drug: Ertapenem 1
RxNorm normalized name: ertapenem 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ertapenem 1 g
Trial: 2745258
Drug: Cefotetan 2
RxNorm normalized name: cefotetan 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotetan 2 g
Trial: 10856310
Drug: Air therapy
RxNorm normalized name: Amlactin Foot Repair Therapy 15% Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air therapy (AT) at 4 l/min
Trial: 10856310
Drug: Oxygen therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen therapy (OT) at baseline
Trial: 9201614
Drug: Pippali Rasayana
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pippali Rasayana (PR) administered at a dose of 1 g p.o. three times daily for 15 days
Trial: 3857627
Drug: Glucose infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose infusion at 2 mg/kg of body weight per min
Trial: 30465339
Drug: Universal adhesive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Universal adhesive treatment for 30 s (adult teeth)
Trial: 24130347
Drug: Antibiotics group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics group (AG) - treated exclusively with antibiotics for 90 days
Trial: 24130347
Drug: Surgical group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical group (SG) - underwent conservative surgery with postoperative antibiotic treatment for 10 days
Trial: 9500747
Drug: TAA aqueous
RxNorm normalized name: ethylcellulose aqueous dispersion type A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAA aqueous nasal spray 220 microg
Trial: 9500747
Drug: TAA aqueous
RxNorm normalized name: ethylcellulose aqueous dispersion type A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAA aqueous nasal spray 440 microg
Trial: 7544732
Drug: Casodex (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casodex (50 mg daily for 24 weeks)
Trial: 2653971
Drug: Calcitonin (415
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitonin (415 pmol iv bolus followed by a 90 minute infusion to reach an overall dose of 62.25 pmol/kg)
Trial: 2308759
Drug: Benzydamine 3%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzydamine 3% cream
Trial: 12108813
Drug: Multisystemic Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multisystemic Therapy (MST)
Trial: 20234144
Drug: Control (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (placebo after indomethacin administration)
Trial: 15790982
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone 2000 microg daily for 12 weeks
Trial: 10429835
Drug: Zanamivir administered
RxNorm normalized name: Zanamivir
DrugBank: Zanamivir (DB00558)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zanamivir administered by intravenous route (up to 600 mg)
Trial: 10429835
Drug: Zanamivir administered
RxNorm normalized name: Zanamivir
DrugBank: Zanamivir (DB00558)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zanamivir administered by oral route
Trial: 10429835
Drug: Zanamivir administered
RxNorm normalized name: Zanamivir
DrugBank: Zanamivir (DB00558)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zanamivir administered by intranasal route
Trial: 10429835
Drug: Zanamivir administered
RxNorm normalized name: Zanamivir
DrugBank: Zanamivir (DB00558)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zanamivir administered by inhaled route (nebuliser and dry powder)
Trial: 7751495
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for depression (12 sessions)
Trial: 393053
Drug: Bromocriptine, 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine, 2.5 mg twice a day
Trial: 16246656
Drug: Buccal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Buccal misoprostol (800 mcg)
Trial: 15491558
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol (800 mcg)
Trial: 11917285
Drug: Amifostine (340
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amifostine (340 mg/m2) plus RT
Trial: 2675427
Drug: Cimetidine, 400
RxNorm normalized name: Cimetidine, 400 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine, 400 mg twice daily for two years or until death
Trial: 341363
Drug: Cimetidine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (200 or 300 mg every 6 hours)
Trial: 27823977
Drug: Nimotuzumab (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimotuzumab (200 mg, i.v. weekly) plus gefitinib (250 mg p.o. daily)
Trial: 23026548
Drug: BTDS 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BTDS 10 mcg/hour patches applied for seven days
Trial: 15374364
Drug: Idebenone (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idebenone (45 mg twice daily orally)
Trial: 30140327
Drug: Forced oscillation
RxNorm normalized name: benzalkonium chloride Topical Solution [Clean Force]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Forced oscillation technique (FOT) with 200 mcg salbutamol by MDI
Trial: 25757036
Drug: SPORT surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SPORT surgical treatment
Trial: 25757036
Drug: NSQIP surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSQIP surgical treatment
Trial: 14666760
Drug: Hydergine, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydergine, 2 mg orally, 3 times a day for 2 months
Trial: 30227969
Drug: Honey plus
RxNorm normalized name: Honey
DrugBank: Honey (DB14242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Honey plus oral acyclovir
Trial: 27997586
Drug: Syntometrine® administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syntometrine® administration
Trial: 12581080
Drug: Topical 3%
RxNorm normalized name: sulfur topical 3% topical soap
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 3% diclofenac in 2.5% hyaluronan gel
Trial: 12581080
Drug: Placebo (vehicle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (vehicle only, hyaluronan gel)
Trial: 8501574
Drug: GBS hyperimmune
RxNorm normalized name: GB-13
DrugBank: GB-13 (DB18387)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GBS hyperimmune IVIG, 500 mg/kg
Trial: 3326679
Drug: Controlled-release hydralazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release hydralazine QD
Trial: 3326679
Drug: Beta-blocker (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocker (80 mg/day of nadolol)
Trial: 30742378
Drug: Nefradoz 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nefradoz 1 capsule 2 times a day (n=45)
Trial: 27784460
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine (TCM) treatment (cinobufacini injection, herbal decoction, and Chinese acupoint application)
Trial: 25886416
Drug: Bupivacaine group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine group (3 mg bupivacaine + 10 ug fentanyl)
Trial: 25886416
Drug: Lidocaine group
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine group (20 mg lidocaine + 25 ug fentanyl)
Trial: 16682486
Drug: Western diet
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western diet supplemented with wheat bran (24 g/day)
Trial: 4699595
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg betamethasone in saline
Trial: 31188172
Drug: Lidocaine plus
RxNorm normalized name: Icy Hot Lidocaine Plus Menthol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine plus 2 mL (8 mg) dexamethasone (Dexa)
Trial: 31188172
Drug: Lidocaine plus
RxNorm normalized name: Icy Hot Lidocaine Plus Menthol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine plus 2 mL (1 µg/kg) dexmedetomidine (Dexm)
Trial: 28724657
Drug: Iron and
RxNorm normalized name: beef,iron and wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron and folic acid (IFA; 60 mg Fe + 400 μg folic acid/d)
Trial: 26458895
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 mg daily for 14 days
Trial: 23977723
Drug: Butyrylated high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butyrylated high amylose maize starch (HAMSB) 20 g twice daily for 28 days
Trial: 11350463
Drug: Metoclopramide 20
RxNorm normalized name: metoclopramide 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 20 mg intravenously
Trial: 18006188
Drug: Prochlorperazine 10
RxNorm normalized name: prochlorperazine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prochlorperazine 10 mg intravenously
Trial: 12951616
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UCA) 10 mg/kg/day until surgery, n=30
Trial: 25828692
Drug: Etoricoxib (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoricoxib (120 mg pre-emptive administration)
Trial: 25828692
Drug: Etoricoxib (post-operative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoricoxib (post-operative treatment)
Trial: 25828692
Drug: Placebo (post-operative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (post-operative treatment)
Trial: 25436273
Drug: 8-week stress
RxNorm normalized name: lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 8-week stress management programme (diaphragmatic breathing, progressive muscle relaxation, guided imagery, twice a day)
Trial: 10403354
Drug: Antibiotics (erythromycin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics (erythromycin, doxycycline, trimethoprim/sulfamethoxazole)
Trial: 7338577
Drug: Bumetanide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bumetanide (1 to 2 mg daily for three days)
Trial: 23876569
Drug: Meditation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meditation therapy
Trial: 19697195
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg natural micronised progesterone intravaginally once daily from 20‐24 weeks' gestation until 36 weeks
Trial: 19697195
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg natural micronised progesterone intravaginally
Trial: 29729588
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of fluoxetine
Trial: 8480824
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg of fluoxetine
Trial: 18784099
Drug: Physical and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical and medical therapy alone (Control)